Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy

ClinicalTrials.gov ID: NCT01681121

Public ClinicalTrials.gov record NCT01681121. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 28, 2026, 6:10 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multi-center Study of the Safety and Efficacy of ADX-N05 in the Treatment of Excessive Daytime Sleepiness in Subjects With Narcolepsy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a study to evaluate the safety and effectiveness of ADX-N05 compared to placebo in the treatment of excessive daytime sleepiness in adults with narcolepsy.

Study identification

NCT ID
NCT01681121
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Jazz Pharmaceuticals
Industry
Enrollment
93 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2012 (Type not available)
Primary completion
Aug 2013 (Actual)
Completion
Aug 2013 (Actual)
Last update posted
May 28, 2021

2012 – 2013

United States locations

U.S. sites
28
U.S. states
17
U.S. cities
26
Facility City State ZIP Site status
Sleep Disorders Center of Alabama Birmingham Alabama 35213 —
Pulmonary Associates Phoenix Arizona 85006 —
Stanford Sleep Medicine Center Redwood City California 94063 —
Pacific Research Network San Diego California 92103 —
Sleep-Alertness Disorders Center Aurora Colorado 80012 —
PAB Clinical Research Brandon Florida 33511 —
Clinical Research Group of St. Petersburg St. Petersburg Florida 33707 —
NeuroTrials Research, Inc. Atlanta Georgia 30342 —
Sleep Disorders Center of Georgia Atlanta Georgia 30342 —
SleepMed of Central Georgia Macon Georgia 31201 —
Chicago Research Center Chicago Illinois 60634 —
Community Research Crestview Hills Kentucky 41017 —
Kentucky Research Group Louisville Kentucky 40217 —
The Center for Sleep and Wake Disorders Chevy Chase Maryland 20815 —
Pulmonary and Critical Care Associates of Baltimore Towson Maryland 21204 —
Neurocare, Inc. Newton Massachusetts 02459 —
Minnesota Lung Center and Sleep Institute Edina Minnesota 55435 —
Washington University St Louis Missouri 63108 —
Rex Sleep Disorders Center Raleigh North Carolina 27607 —
Wake Research Associates Raleigh North Carolina 27612 —
Mercy St. Vincent Medical Center Toledo Ohio 43623 —
Center for Sleep Medicine Philadelphia Pennsylvania 19118 —
SleepMed of South Carolina Columbia South Carolina 29201 —
Future Search Trials of Neurology Austin Texas 78731 —
Sleep Medicine Associates of Texas Dallas Texas 75231 —
Todd J. Swick, MD, PA Houston Texas 77063 —
Metroplex Pulmonary and Sleep Center McKinney Texas 75069 —
Sleep Therapy and Research Center San Antonio Texas 78229 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01681121, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 28, 2021 · Synced Oct 28, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01681121 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →